Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase

Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase

US Patent 5008283 · Granted Apr 16, 1991

Estimated economic value: $27,384,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

2-Oxidole-1-carboxamide pharmaceutical agents for the treatment of alzheimer's d1996
Use of tenidap to reduce total serum cholesterol, LDL cholesterol and triglyceri1992
Tenidap as an inhibitor of the release of elastase by neutrophils1991